Skip to main content
. 2022 Aug 22;10(5):e01034-22. doi: 10.1128/spectrum.01034-22

TABLE 1.

Precision estimates for tixagevimab and cilgavimab, including and excluding the outlier

Parameter Precision estimate [%CV (95% CI)]a
Including outlier Excluding outlier
Repeatability 38 (22–145) 27 (0–59)
Interassay 105 (78–164) 34 (27–45)
Intermediate (overall) 122 (92–186) 45 (35–63)
a

CV, coefficient of variation; CI, confidence interval.